OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 129 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $16,000 | -93.8% | 28,595 | -80.9% | 0.00% | -100.0% |
Q4 2015 | $258,000 | -25.4% | 149,520 | -8.9% | 0.00% | 0.0% |
Q3 2015 | $346,000 | -59.7% | 164,127 | -5.3% | 0.00% | -50.0% |
Q2 2015 | $858,000 | -33.5% | 173,346 | +5.1% | 0.00% | -33.3% |
Q1 2015 | $1,291,000 | +67.0% | 164,923 | +29.3% | 0.00% | +50.0% |
Q4 2014 | $773,000 | -59.4% | 127,571 | -71.5% | 0.00% | -60.0% |
Q3 2014 | $1,905,000 | -19.6% | 447,268 | +16.7% | 0.01% | -16.7% |
Q2 2014 | $2,368,000 | -8.7% | 383,188 | -4.0% | 0.01% | -14.3% |
Q1 2014 | $2,595,000 | +42.3% | 399,213 | +28.1% | 0.01% | -12.5% |
Q2 2013 | $1,823,000 | – | 311,662 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,235,000 | $5,261,000 | 5.04% |
Cheyne Capital Management (UK) LLP | 693,642 | $2,958,000 | 1.05% |
Rock Springs Capital Management LP | 1,250,000 | $5,325,000 | 0.82% |
NEA Management Company, LLC | 3,709,000 | $15,800,000 | 0.80% |
Rhenman & Partners Asset Management AB | 494,000 | $2,104,000 | 0.62% |
Palo Alto Investors LP | 1,931,324 | $8,227,000 | 0.62% |
PFM Health Sciences, LP | 4,838,324 | $20,611,000 | 0.47% |
CQS Cayman LP | 1,750,000 | $7,455,000 | 0.44% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,700,371 | $7,243,000 | 0.37% |
SAMLYN CAPITAL, LLC | 2,299,000 | $9,794,000 | 0.20% |